[1] |
PENG Yong, FAN Jianfeng, XIONG Xuhua, XIAO Dongping, GAO Zhaobo, ZHENG Chunhua.
Effect of iron dextran dispersible tablets on heart failure patients with iron deficiency
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(2): 178-183.
|
[2] |
YANG Sheng, WANG Deguo.
Effects of sakubatril valsartan combined with dagliflozin in the treatment of patients with HFrEF and the effect on serum cTnⅠ and BNP levels
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(9): 1010-1015.
|
[3] |
PENG Juan, FAN Linlin, LI Ranyi, LI Xiaoyu, LV Qianzhou, ZOU Yunzeng.
Progress of pharmacotherapy for heart failure
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(4): 373-381.
|
[4] |
ZHANG Xiaoyi, KUAI Zheng, ZOU Yunzeng.
Research progress of β2 microglobulin
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(4): 390-396.
|
[5] |
CAI Zichun, JIANG Yuanzhen, ZHANG Chunsheng, LI Jiming.
Research progress and application prospects of circRNA in cardiovascular diseases
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(4): 397-404.
|
[6] |
LIU Ping, QIU Bo, WU Huizhen.
Pharmacology and clinical evaluation of vericiguat in the treatment of heart failure
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(2): 212-218.
|
[7] |
XU Yonghua, SHI Xianghong.
Analysis of the efficacy of torasemide combined with levocarnitine in the treatment of chronic heart failure
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(6): 647-652.
|
[8] |
HUANG Ting, WANG Hegui.
Research progress in regulation of heart failure by β-adrenergic-receptor-PKA-AKAP signaling pathway
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2018, 23(5): 592-596.
|
[9] |
YAN Mo-lei, YAN Jing, YU Yi-hua, CHEN Jin, CAI Guo-long.
Impact of dopamine and norepinephrine on sublingual microcirculation of the septic shock
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2013, 18(5): 565-569.
|
[10] |
LI Shi-Yu, MA Yu-Ling, GUO Xiang-Jie, LI Zhi-Hong, FENG Guo-Wei.
Effects of sodium nitroprusside on cardiac function and the level of nitric oxide, lipid peroxide and atrial natriuretic factor of the elderly patients with congestive heart failure
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2003, 8(3): 311-313.
|
[11] |
.
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2001, 6(3): 271-271.
|
[12] |
.
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 1999, 4(2): 132-133.
|
[13] |
LI Xiang-dong, WANG An-cai.
Differential diagnostic and prognostic values of measurements of N-terminal pro-brain natriuretic peptide, cardiac troponin I and heart-type fatty acid binding protein in patients with dyspnea
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2015, 20(5): 562-566.
|
[14] |
GUI Le, ZHU Jian-hua, CHEN Qing-hui.
Losartan inhibits renal sympathetic nerve activity in Paraventricular nucleus in chronic heart failure rat
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2009, 14(11): 1212-1215.
|
[15] |
ZHONG Mai-ye, JI Qiu-he.
Research progress on the treatment of compensatory Congestive Heart Failure with recombinant human brain natriuretic peptide
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2009, 14(4): 471-474.
|